Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
- WaferGen Biosystems
- 7400 Paseo Padre Parkway
- Fremont CA, 94555
- UNITED STATES
Increasing interest in personalized medicine has led to the need for accurate, highly sensitive, high-throughput gene expression data by researchers, clinicians and pharmaceutical companies. WaferGen is addressing that need with the SmartChip System. It is the first system to combine the high-throughput capability and cost efficiencies of microarrays, with the sensitivity and accuracy of real-time PCR, enabling researchers to advance from biomarker discovery to target validation on a single integrated platform.